Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-04

Clinical Trial Update: The Contribution of Incretin Hormones to the Amelioration of Glucose Metabolism After Roux-en-Y Gastric Bypass [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial investigated the contribution of incretin hormones to improved glucose metabolism after Roux-en-Y gastric bypass; the study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Adrian Vella | Conditions: Type 2 Diabetes Mellitus | EARLY_Phase 1 | Status: COMPLETED